DCOY is trading at $13.51 (144.84%) up today after Decoy Therapeutics announced a $3.5 million private placement to advance its lead asset into clinical trials.
- The financing deal includes milestone-based warrants that could provide additional capital to the company upon reaching specific development targets.
- Shares surged significantly past the private placement offering price of $5.91, suggesting strong investor confidence in the company's clinical roadmap.
- Analysts view the move as a company-specific catalyst driven by the funding milestone rather than general biotech sector sentiment.